ASX:TTS Tatts Group (TTS) Stock Price, News & Analysis → Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad) Free TTS Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Tatts Group alerts: Email Address Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> About Tatts Group Stock (ASX:TTS)Tatts Group Limited is engaged in the operation of regulated lotteries, conducting wagering and sports betting, conducting game machine monitoring and supply of jackpot, and provision of third party installation and maintenance services for gaming, wagering, lottery and other transactional equipment and systems. The Company's segments include Lotteries, which includes the operation of lottery licenses, the operation of a Lottery Operator Agreement in Queensland, South Australia, and an agreement in Northern Territory to conduct lotteries; Wagering, which includes totalisator and fixed odds betting on thoroughbred, harness, greyhounds and other sporting events; Maxgaming, which includes gaming machine monitoring and services in Queensland, New South Wales and the Northern Territory, and Bytecraft Systems, which includes warehousing, installation, relocation and maintenance of gaming machines, lottery and wagering terminals, and other transaction devices in Australia and New Zealand.Read More Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> TTS Stock News HeadlinesJuly 17, 2022 | fool.com.auHow you could win big with these 3 gambling sharesJune 29, 2022 | afr.comA punishing workload for The Star’s CookeApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.June 28, 2022 | marketwatch.comStar Entertainment Appoints Tyro's Cooke as Managing Director, CEO -- UpdateJune 2, 2022 | investing.comTatts Group Ltd (TTS)May 23, 2022 | afr.comBankers win as big mergers get reversedMay 3, 2022 | dailymail.co.ukThe wild tattoos The Wiggles don't want you to know they're hiding: Anthony Field reveals the REAL reason why the children's group always wear long-sleeved skivviesMarch 25, 2022 | msn.comTatts him! Mum hunts for man whose name she had tattooed on her bum in MagalufApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.December 22, 2021 | dailymail.co.ukKentucky man 'who traveled to Syria to join ISIS' appears in federal courtDecember 21, 2021 | dailymail.co.ukHailey Bieber gets 'New York' neck tattoo... after urging Justin Bieber to stop getting neck tattsOctober 8, 2021 | dailymail.co.ukIs THIS the Zodiac Killer? Group of experts claim they've uncovered serial killer's identity after linking painter who died in 2018 to unsolved murder hundreds of miles from ...October 7, 2021 | dailymail.co.ukExtinction Rebellion protestor is tackled to the ground after storming Louis Vuitton's Paris Fashion Week show with 'overconsumption = extinction' signOctober 7, 2021 | dailymail.co.ukSinema greeted by more protesters - this time at DC airportSee More Headlines Receive TTS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tatts Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/07/2018Today4/19/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorManufacturing Industry Electronic Computer Manufacturing Sub-IndustryN/A Current SymbolASX:TTS CUSIPN/A CIKN/A Webwww.tattsgroup.com Phone+61-7-34354500FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesRobert Michael Sean CookeChief Executive Officer, Managing DirectorNeale O'ConnellChief Financial OfficerMandy RossChief Information OfficerMegan MagillChief Marketing OfficerAshleigh LoughnanExecutive General Manager – People, Property & ProcurementAndrew CollinsHead - Corporate DevelopmentJohn CorryChief Operating Officer – GeorgeFrank MakryllosChief Operating Officer – MAXBrendan ParnellChief Operating Officer - Wagering, UBETMaree PataneChief AuditorMore ExecutivesKey Competitors(BAV.L)LON:BAV(BVII)OTCMKTS:BVII(CBNR)OTCMKTS:CBNR(DGTC)OTCMKTS:DGTC(DTOR)OTCMKTS:DTORView All Competitors TTS Stock Analysis - Frequently Asked Questions How were Tatts Group's earnings last quarter? Tatts Group Limited (ASX:TTS) released its quarterly earnings data on Wednesday, February, 7th. The company reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.09 by $0.00. What other stocks do shareholders of Tatts Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Tatts Group investors own include BHP Group (BHP), Suncorp Group (SUN), NYX Gaming Group (NYX), Fonterra Shareholders Fund (FSF) and BHP Group (BHP). This page (ASX:TTS) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIYour Money is Not SafeAmerican AlternativeHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceSHOCKING Crypto Leak…Crypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tatts Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.